Investor Relations

Thursday 25 7月y 2024
H1 and Q2 2024 results


Investor enquiries

Main Contacts

安迪·巴内特

安迪·巴内特

Head of Investor Relations

Morgan Sanford

Morgan Sanford

肿瘤学

Christer Gruvris

Christer Gruvris

BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
金融 & 固定收益

Lauren Swales

Lauren Swales

罕见的疾病

伊莎贝尔吉布森

伊莎贝尔吉布森

肿瘤学

Philip Sparks

Philip Sparks

BioPharmaceuticals
(疫苗 & Immune Therapies)

Rachel Korolyshun

Rachel Korolyshun

罕见的疾病,
Environment, Social and 治理

Elizabeth Walton

Elizabeth Walton

BioPharmaceuticals
(呼吸 & 免疫学), Environment, Social and 治理

澳门在线赌城娱乐

Shareholder Helpline


  • Shareholder information

    Please find relevant shareholder information and shareholder tools on this page


  • Shareholder 常见问题

    Answers to frequently asked shareholder questions


  • 治理

    We apply the principles of good corporate governance in the UK Corporate 治理 Code and related guidance